Annual Financials for Sanofi
Assets
Fiscal year is January-December. All values EUR millions. |
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Cash & Short Term Investments |
6.93B | 9.74B | 13.92B | 10.1B | 12.74B | |
Cash Only |
6.93B | 9.74B | 13.92B | 10.1B | 12.74B | |
Short-Term Investments |
- | - | - | - | - | |
Cash & Short Term Investments Growth |
- | 40.68% | 42.84% | -27.43% | 26.12% | |
Cash & ST Investments / Total Assets |
6.22% | 8.64% | 12.16% | 8.40% | 10.05% | |
Total Accounts Receivable |
9.35B | 10.08B | 9.95B | 9.79B | 10.75B | |
Accounts Receivables, Net |
7.26B | 7.94B | 7.49B | 7.57B | 8.42B | |
Accounts Receivables, Gross |
7.43B | 8.09B | 7.63B | 7.71B | 8.54B | |
Bad Debt/Doubtful Accounts |
(170M) | (153M) | (142M) | (137M) | (113M) | |
Other Receivables |
2.09B | 2.15B | 2.46B | 2.22B | 2.32B | |
Accounts Receivable Growth |
- | 7.90% | -1.29% | -1.67% | 9.80% | |
Accounts Receivable Turnover |
3.69 | 3.58 | 3.62 | 3.86 | 4.00 | |
Inventories |
7.48B | 7.99B | 8.35B | 8.72B | 8.96B | |
Finished Goods |
2.37B | 2.39B | 2.52B | 2.41B | 2.5B | |
Work in Progress |
4.09B | 4.52B | 4.86B | 5.03B | 4.99B | |
Raw Materials |
1.02B | 1.09B | 975M | 1.28B | 1.47B | |
Progress Payments & Other |
- | - | - | - | - | |
Other Current Assets |
832M | 792M | 1.48B | 1.96B | 1.58B | |
Miscellaneous Current Assets |
363M | 299M | 958M | 1.35B | 870M | |
Total Current Assets |
24.58B | 28.61B | 33.7B | 30.56B | 34.03B | |
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
Net Property, Plant & Equipment |
9.65B | 11.02B | 10.56B | 11.98B | 11.68B | |
Property, Plant & Equipment - Gross |
22.7B | 24.87B | 24.37B | 26.76B | 25.74B | |
Buildings |
6.88B | 7.28B | 6.83B | 7.17B | 7.33B | |
Land & Improvements |
283M | 255M | 236M | 240M | 237M | |
Computer Software and Equipment |
- | - | - | - | - | |
Other Property, Plant & Equipment |
2.58B | 2.59B | 2.52B | 2.66B | 2.52B | |
Accumulated Depreciation |
13.05B | 13.85B | 13.8B | 14.78B | 14.06B | |
Total Investments and Advances |
5.55B | 5.3B | 2.13B | 2.43B | 2.77B | |
Other Long-Term Investments |
2.15B | 1.71B | 1.93B | 2.18B | 2.09B | |
Long-Term Note Receivable |
620M | 685M | 537M | 485M | 452M | |
Intangible Assets |
66.12B | 61.09B | 62.71B | 69.46B | 71.53B | |
Net Goodwill |
44.24B | 44.52B | 44.36B | 48.06B | 49.89B | |
Net Other Intangibles |
21.89B | 16.57B | 18.34B | 21.41B | 21.64B | |
Other Assets |
271M | 595M | 600M | 731M | 882M | |
Tangible Other Assets |
68M | 325M | 331M | 264M | 327M | |
Total Assets |
111.41B | 112.74B | 114.41B | 120.24B | 126.72B | |
Assets - Total - Growth |
- | 1.19% | 1.49% | 5.09% | 5.39% | |
Liabilities & Shareholders' Equity
|
2018 | 2019 | 2020 | 2021 | 2022 |
5-year trend |
ST Debt & Current Portion LT Debt |
2.63B | 4.82B | 3B | 3.45B | 4.45B | |
Short Term Debt |
2.63B | 4.55B | 2.77B | 3.18B | 4.17B | |
Current Portion of Long Term Debt |
4M | 261M | 232M | 269M | 277M | |
Accounts Payable |
5.04B | 5.31B | 5.3B | 6.18B | 6.81B | |
Accounts Payable Growth |
- | 5.40% | -0.34% | 16.71% | 10.24% | |
Income Tax Payable |
733M | 613M | 951M | 737M | 574M | |
Other Current Liabilities |
8.97B | 9.64B | 10B | 10.93B | 12.13B | |
Dividends Payable |
- | - | - | - | - | |
Accrued Payroll |
1.99B | 1.98B | - | - | - | |
Miscellaneous Current Liabilities |
6.98B | 7.66B | 10B | 10.93B | 12.13B | |
Total Current Liabilities |
17.38B | 20.38B | 19.25B | 21.3B | 23.96B | |
Long-Term Debt |
22.01B | 21.12B | 20.68B | 18.96B | 16.76B | |
Long-Term Debt excl. Capitalized Leases |
21.99B | 20.13B | 19.75B | 17.12B | 14.86B | |
Non-Convertible Debt |
21.99B | 20.13B | 19.75B | 17.12B | 14.86B | |
Convertible Debt |
- | - | - | - | - | |
Capitalized Lease Obligations |
18M | - | - | - | - | |
Provision for Risks & Charges |
6.88B | 7.35B | 7B | 6.43B | 5.82B | |
Deferred Taxes |
(1.2B) | (3.14B) | (2.41B) | (2.98B) | (3.54B) | |
Deferred Taxes - Credit |
3.41B | 2.29B | 1.77B | 1.62B | 1.84B | |
Deferred Taxes - Debit |
4.61B | 5.43B | 4.18B | 4.6B | 5.38B | |
Other Liabilities |
2.69B | 2.48B | 2.47B | 2.91B | 3.18B | |
Other Liabilities (excl. Deferred Income) |
2.69B | 2.48B | 2.47B | 2.91B | 3.18B | |
Deferred Income |
- | - | - | - | - | |
Total Liabilities |
52.37B | 53.63B | 51.16B | 51.21B | 51.57B | |
Non-Equity Reserves |
- | - | - | - | - | |
Total Liabilities / Total Assets |
47.01% | 47.57% | 44.72% | 42.59% | 40.70% | |
Preferred Stock (Carrying Value) |
- | - | - | - | - | |
Redeemable Preferred Stock |
- | - | - | - | - | |
Non-Redeemable Preferred Stock |
- | - | - | - | - | |
Common Equity (Total) |
58.88B | 58.93B | 63.11B | 68.68B | 74.78B | |
Common Stock Par/Carry Value |
2.5B | 2.51B | 2.52B | 2.53B | 2.52B | |
Retained Earnings |
53.11B | 51.78B | 60.15B | 63.01B | 66.73B | |
ESOP Debt Guarantee |
- | - | - | - | - | |
Cumulative Translation Adjustment/Unrealized For. Exch. Gain |
(167M) | 632M | (3.36B) | (857M) | 1.45B | |
Unrealized Gain/Loss Marketable Securities |
- | - | - | - | - | |
Revaluation Reserves |
- | - | - | - | - | |
Treasury Stock |
(153M) | (9M) | (705M) | (939M) | (706M) | |
Common Equity / Total Assets |
52.85% | 52.28% | 55.16% | 57.12% | 59.01% | |
Total Shareholders' Equity |
58.88B | 58.93B | 63.11B | 68.68B | 74.78B | |
Total Shareholders' Equity / Total Assets |
52.85% | 52.28% | 55.16% | 57.12% | 59.01% | |
Accumulated Minority Interest |
159M | 174M | 146M | 350M | 368M | |
Total Equity |
59.04B | 59.11B | 63.25B | 69.03B | 75.15B | |
Liabilities & Shareholders' Equity |
111.41B | 112.74B | 114.41B | 120.24B | 126.72B | |